A statin-loaded reconstituted high-density lipoprotein nanoparticle inhibits atherosclerotic plaque inflammation.
A statin-loaded reconstituted high-density lipoprotein nanoparticle inhibits atherosclerotic plaque inflammation.
复制标题
DOI:
10.1038/ncomms4065
复制
发表时间:
2014
影响因子:
16.6
通讯作者:
Mulder WJ
中科院分区:
文献类型:
--
作者:
Duivenvoorden R;Tang J;Cormode DP;Mieszawska AJ;Izquierdo-Garcia D;Ozcan C;Otten MJ;Zaidi N;Lobatto ME;van Rijs SM;Priem B;Kuan EL;Martel C;Hewing B;Sager H;Nahrendorf M;Randolph GJ;Stroes ES;Fuster V;Fisher EA;Fayad ZA;Mulder WJ
Inflammation is a key feature of atherosclerosis and a target for therapy. Statins have potent anti-inflammatory properties but these cannot be fully exploited with oral statin therapy due to low systemic bioavailability. Here we present an injectable reconstituted high-density lipoprotein (rHDL) nanoparticle carrier vehicle that delivers statins to atherosclerotic plaques. We demonstrate the anti-inflammatory effect of statin-rHDL in vitro and show this effect is mediated through inhibition of the mevalonate pathway. We also apply statin-rHDL nanoparticles in vivo in an apolipoprotein E-knockout mouse model of atherosclerosis and show they accumulate in atherosclerotic lesions where they directly affect plaque macrophages. Finally we demonstrate that a three-month low-dose statin-rHDL treatment regimen inhibits plaque inflammation progression, while a one-week high-dose regimen markedly decreases inflammation in advanced atherosclerotic plaques. Statin-rHDL represents a novel potent atherosclerosis nanotherapy that directly affects plaque inflammation.
登录
查看更多内容
影响因子:
37.8
作者:
Bellosta, S;Paoletti, R;Corsini, A
通讯作者:
Corsini, A
影响因子:
2.8
作者:
Milonas, Christos;Jernberg, Tomas;Stenestrand, Ulf
通讯作者:
Stenestrand, Ulf
影响因子:
24
作者:
Libby, P
通讯作者:
Libby, P
影响因子:
13.6
作者:
BELL F P
通讯作者:
BELL F P
DOI:
10.1073/pnas.042683999
发表时间:
2002-02-19
影响因子:
11.1
作者:
Trogan, E;Choudhury, RP;Fisher, EA
通讯作者:
Fisher, EA